Rimonabant Acomplia is an anorectic anti obesity drug. It is a CB1 cannabinoid receptor antagonist. Its main avenue of effect is reduction in appetite. Obesity is now the most common nutritional disorder in western countries. Defined as a body mass index of greater than 30, it arises from the accumulation of excess fat in the body from overconsumption of fatty foods. Prevalence of obesity in the US and Europe has reached epidemic levels. Data from the World Health Organisation’s MONICA project show that in some parts of Europe over 70% of men aged 55-64 years are clinically obese or overweight (BMI >25) and almost 70% of women in this age group. One in five of all Americans is obese and one in three overweight. Furthermore, increasing rates of childhood obesity are likely to exacerbate the trend towards increasing obesity in adulthood.

Why Rimonabant Acomplia is Miracle Drug ?

Why Rimonabant Acomoplia is called a Miracle Drug ? Do You know, Rimonabant acomplia helps not only to lose weight as well as to reduce waist size and stop alcoholism also at some extent. Many of Teenagers (especially girls) are afraid to quit smoking as it might increase weight, but Rimonabant acomplia helps you to keep your weight in track for quick weight loss.

Rimonabant Acomplia Helps With Weight Loss so order Acomplia online now !

Buy Rimonabant acomplia and start reducing weight and stop smoking now . As it is a CB1 cannabinoid receptor antagonist. Its main avenue of effect is reduction in appetite.

How much weight can I lose by taking Acomplia?

Exhaustive clinical trials conducted with Acomplia on more than 6800 patients yielded substantial results. Patients given Acomplia for a period of one year achieved an average weight loss of six and half kg as compared to just over one and half kg achieved by those on placebo. Most of the weight loss was achieved in the first 9 months of the trial with Acomplia.

Acomplia was also found to reduce the risk of regaining weight. When a group of patients from one of the clinical trials was re-randomized and split into Acomplia and placebo groups, those patients who continued on Acomplia achieved a total weight loss of 7.5 kg over the two year trial period. On the other hand patients who were transferred to placebo achieved a much lower weight loss of only 3.1 kg over the same period.

The best part about Acomplia is that it brings about sizeable reduction in the waist circumference – nearly 6 to 7 cm on an average. This measure is an indication of intra-abdominal fat and is believed to be more important that BMI. If you have a large waist circumference, you should buy Acomplia for reducing it.